Tenascin cytotactin epidermal growth factor-like repeat binds epidermal growth factor receptor with low affinity

Journal of Cellular Physiology

Volumn 211, Issue 3, 2007, Pages 748-758

  Iyer, Anand Krishnan V ^a   Tran, Kien T ^a   Borysenko, Christopher W ^a   Cascio, Michael ^a   Camacho, Carlos J ^a   Blair, Harry C ^a   Bahar, Ivet ^a   Wells, Alan ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; TENASCIN;

ARTICLE; CIRCULAR DICHROISM; COMPUTER MODEL; EQUILIBRIUM CONSTANT; INTERNALIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN STRUCTURE; RECEPTOR AFFINITY; RECEPTOR BINDING; SURFACE PLASMON RESONANCE;

AMINO ACID SEQUENCE; EPIDERMAL GROWTH FACTOR; EXTRACELLULAR MATRIX PROTEINS; HUMANS; LIGANDS; MODELS, CHEMICAL; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, EPIDERMAL GROWTH FACTOR; REPETITIVE SEQUENCES, NUCLEIC ACID; SIGNAL TRANSDUCTION; SURFACE PLASMON RESONANCE; TENASCIN;

EID: 34247595352     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20986     Document Type: Article

References (63)

1. Bahar I. 1999. Dynamics of proteins and biomolecular complexes: Inferring functional motions from structure. Rev Chem Eng 15:319-349.
2. Bahar I, Jernigan RL. 1998. Vibrational dynamics of transfer RNAs: Comparison of the free and synthetase-bound forms. J Mol Biol 281:871-884.
3. Bahar I, Rader AJ. 2005. Coarse-grained normal mode analysis in structural biology. Curr Opin Struct Biol 15:586-592.
4. Bahar I, Atilgan AR, Erman B. 1997. Direct evaluation of thermal fluctuations in proteins using a single-parameter harmonic potential. Fold Des 2:173-181.
5. Brown PM, Debanne MT, Grothe S, Bergsma D, Caron M, Kay C, O'Connor-McCourt MD. 1994. The extracellular domain of the epidermal growth factor receptor. Studies on the affinity and stoichiometry of binding, receptor dimerization and a binding-domain mutant. Eur J Biochem 225:223-233.
6. Cai M, Onoda K, Takao M, Kyoko IY, Shimpo H, Yoshida T, Yada I. 2002. Degradation of tenascin-C and activity of matrix metalloproteinase-2 are associated with tumor recurrence in early stage non-small cell lung cancer. Clin Cancer Res 8:1152-1156.
7. Camacho CJ, Zhang C. 2005. FastContact: Rapid estimate of contact and binding free energies. Bioinformatics.
8. Carman CV, Springer TA. 2003. Integrin avidity regulation: Are changes in affinity and conformation underemphasized? Curr Opin Cell Biol 15:547-556.
9. Carpenter G, Cohen S. 1990. Epidermal growth factor. J Biol Chem 265:7709-7712.
10. Chen P, Gupta K, Wells A. 1994a. Cell movement elicited by epidermal growth factor receptor requires kinase and autophosphorylation but is separable from mitogenesis. J Cell Biol 124:547-555.
11. Chen P, Xie H, Sekar MC, Gupta K, Wells A. 1994b. Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement. J Cell Biol 127:847-857.
12. Citri A, Yarden Y. 2006. EGF-ERBB signalling: Towards the systems level. Nat Rev-Mol Cell Biol 7:505-516.
13. De Crescenzo G, Grothe S, Lortie R, Debanne MT, O'Connor-McCourt M. 2000. Real-time kinetic studies on the interaction of transforming growth factor alpha with the epidermal growth factor receptor extracellular domain reveal a conformational change model. Biochemistry 39:9466-9476.
14. Demiret MC, Atilgan AR, Jernigan RL, Erman B, Bahar I. 1998. Identification of kinetically hot residues in proteins. Protein Sci 7:2522-2532.
15. Domagala T, Konstantopoulos N, Smyth F, Jorissen RN, Fabri L, Geleick D, Lax I, Schlessinger J, Sawyer W, Hewlett GJ, Burgess AW, Nice EC. 2000. Stoichiometry, kinetic and binding analysis of the interaction between epidermal growth factor (EGF) and the extracellular domain of the EGF receptor. Growth Factors 18:11-29.
16. French AR, Tadaki DK, Niyogi SK, Lauffenburger DA. 1995. Intracellular trafficking of epidermal growth factor family ligands is directly influenced by the pH sensitivity of the receptor/ligand interaction. J Biol Chem 270:4334-4340.
17. Garrett TP, McKern NM, Lou M, Elleman TC, Adams TE, Lovrecz GO, Zhu HJ, Walker F, Frenkel MJ, Hoyne PA, Jorissen RN, Nice EC, Burgess AW, Ward CW. 2002. Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha. Cell 110:763-773.
18. Glading A, Uberall F, Keyse SM, Lauffenburger DA, Wells A. 2001. Membrane proximal ERK signaling is required for M-calpain activation downstream of epidermal growth factor receptor signaling. J Biol Chem 276:23341-23348.
19. Haugh JM, Meyer T. 2002. Active EGF receptors have limited access to PtdIns{4,5)P(2) in endosomes: Implications for phospholipase C and PI 3-kinase signaling. J Cell Sci 115:303-310.
20. Haugh JM, Huang AC, Wiley HS, Wells A, Lauffenburger DA. 1999a. Internalized epidermal growth factor receptors participate in the activation of p21(ras) in fibroblasts. J Biol Chem 274:34350-34360.
21. Haugh JM, Schooler K, Wells A, Wiley HS, Lauffenburger DA. 1999b. Effect of epidermal growth factor receptor internalization on regulation of the phospholipase C-gamma1 signaling pathway. J Biol Chem 274:8958-8965.
22. Hohenester E, Engel J. 2002. Domain structure and organisation in extracellular matrix proteins. Matrix Biol 21:115-128.
23. Ilunga K, Nishiura R, Inada H, El-Karef A, Imanaka-Yoshida K, Sakakura T, Yoshida T. 2004. Co-stimulation of human breast cancer cells with transforming growth factor-beta and tenascin-C enhances matrix metalloproteinase-9 expression and cancer cell invasion. Int J Exp Pathol 85:373-379.
24. Jian B, Jones PL, Li Q, Mohler ER III, Schoen FJ, Levy RJ. 2001. Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis. Am J Pathol 159:321-327.
25. Johnson WC, Jr. 1990. Protein secondary structure and circular dichroism: A practical guide. Proteins 7:205-214.
26. Jones FS, Jones PL. 2000. The tenascin family of ECM glycoproteins: Structure, function, and regulation during embryonic development and tissue remodeling. Dev Dyn 218:235-259.
27. Juuti A, Nordling S, Louhimo J, Lundin J, Haglund C. 2004. Tenascin C expression is upregulated in pancreatic cancer and correlates with differentiation. J Clin Pathol 57:1151-1155.
28. Kalembeyi I, Inada H, Nishiura R, Imanaka-Yoshida K, Sakakura T, Yoshida T. 2003. Tenascin-C upregulates matrix metalloproteinase-9 in breast cancer cells: Direct and synergistic effects with transforming growth factor beta1. Int J Cancer 105:53-60.
29. Kim JH, Saito K, Yokoyama S. 2002. Chimeric receptor analyses of the interactions of the ectodomains of ErbB-1 with epidermal growth factor and of those of ErbB-4 with neuregulin. Eur J Biochem 269:2323-2329.
30. Kim DE, Chivian D, Baker D. 2004. Protein structure prediction and analysis using the Robetta server. Nucleic Acids Res 32 (Web Server issue): W526-531.
31. Kramer RH, Lenferink AEG, vanBueren-Koorneef IL, vanderMeer A, vandePoll MLM, vanZoelen EJJ. 1994. Identification of the high affinity binding site of transforming growth factor-a (TGF-a) for the chicken epidermal growth factor (EGF) receptor using EGF/TGF-a chimeras. J Biol Chem 269:8708-8711.
32. Lambert C, Leonard N, De Bolle X, Depiereux E. 2002. ESyPred3D: Prediction of proteins 3D structures. Bioinformatics 18:1250-1256.
33. Lobley A, Whitmore L, Wallace BA. 2002. DICHROWEB: An interactive website for the analysis of protein secondary structure from circular dichroism spectra. Bioinformatics 18:211-212.
34. Ma J. 2005. Usefulness and limitations of normal mode analysis in modeling dynamics of biomolecular complexes. Structure 13:373-380.
35. Masui H, Wells A, Lazar CS, Rosenfeld MG, Gill GN. 1991. Enhanced tumorigenesis of NR6 cells which express non-down-regulating epidermal growth factor receptors. Cancer Res 51:6170-6175.
36. Ogiso H, Ishitani R, Nureki O, Fukai S, Yamanaka M, Kim JH, Saito K, Sakamoto A, Inoue M, Shirouzu M, Yokoyama S. 2002. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell 110:775-787.
37. Paas Y, Devillers-Thiery A, Teichberg VI, Changeux JP, Eisenstein M. 2000. How well can molecular modelling predict the crystal structure: The case of the ligand-binding domain of glutamate receptors. Trends Pharmacol Sci 21:87-92.
38. Pearson WR, Lipman DJ. 1988. Improved tools for biological sequence comparison. Proc Natl Acad Sci USA 85:2444-2448.
39. Pennock S, Wang Z. 2003. Stimulation of cell proliferation by endosomal epidermal growth factor receptor as revealed through two distinct phases of signaling. Mol Cell Biol 23:5803-5815.
40. Prasad JC, Comeau SR, Vajda S, Camacho CJ. 2003. Consensus alignment for reliable framework prediction in homology modeling. Bioinformatics 19:1682-1691.
41. Prasad JC, Vajda S, Camacho CJ. 2004. Consensus alignment server for reliable comparative modeling with distant templates. Nucleic Acids Res 32 (Web Server issue): W50-54.
42. Rajamani D, Thiel S, Vajda S, Camacho CJ. 2004. Anchor residues in protein-protein interactions. Proc Natl Acad Sci USA 101:11287-11292.
43. Schenk S, Quaranta V. 2003. Tales from the crypt[ic] sites of the extracellular matrix. Trends Cell Biol 13:366-375.
44. Schenk S, Hintermann E, Bilban M, Koshikawa N, Hojilla C, Khokha R, Quaranta V. 2003. Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution. J Cell Biol 161:197-209.
45. Schwede T, Kopp J, Guex N, Peitsch MC. 2003. SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Res 31:3381-3385.
46. Siri A, Knauper V, Veirana N, Caocci F, Murphy G, Zardi L. 1995. Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases. J Biol Chem 270:8650-8654.
47. Soderquist AM, Carpenter G. 1984. Glycosylation of the epidermal growth factor receptor in A-431 cells. The contribution of carbohydrate to receptor function. J Biol Chem 259:12586-12594.
48. Swindle CS, Tran KT, Johnson TD, Banerjee P, Mayes AM, Griffith L, Wells A. 2001. Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor. J Cell Biol 154:459-468.
49. Tobi D, Bahar I. 2005. Structural changes involved in protein binding correlate with intrinsic motions of proteins in the unbound state. Proc Natl Acad Sci USA 102:18908-18913.
50. Tran KT, Griffith L, Wells A. 2004. Extracellular matrix signaling through growth factor receptors during wound healing. Wound Repair Regen 12:262-268.
51. Tsunoda T, Inada H, Kalembeyi I, Imanaka-Yoshida K, Sakakibara M, Okada R, Katsuta K. Sakakura T, Majima Y, Yoshida T. 2003. Involvement of large tenascin-C splice variants in breast cancer progression. Am J Pathol 162:1857-1867.
52. van der Merwe PA, Barclay AN, Mason DW, Davies EA, Morgan BP, Tone M, Krishnam AK, Ianelli C, Davis SJ. 1994. Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59. Biochemistry 33:10149-10160.
53. Wang XQ, Sun P, O'Gorman M, Tai T, Paller AS. 2001. Epidermal growth factor receptor glycosylation is required for ganglioside GM3 binding and GM3-mediated suppression [correction of suppression] of activation. Glycobiology 11:515-522.
54. Wells A. 1999. EGF receptor. Int J Biochem Cell Biol 31:637-643.
55. Wells A. 2000. Tumor invasion: Role of growth factor-induced cell motility. Adv Cancer Res 78:31-101.
56. Wells A, Welsh JB, Lazar CS, Wiley HS, Gill GN, Rosenfeld MG. 1990. Ligand-induced transformation by a noninternalizing epidermal growth factor receptor. Science 247:962-964.
57. Whitmore L, Wallace BA. 2004. DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data. Nucleic Acids Res 32 (Web Server issue): W668-673.
58. Wiley HS, Herbst JJ, Walsh BJ, Lauffenburger DA, Rosenfeld MG, Gill GN. 1991. The role of tyrosine kinase activity in endocytosis, compartmentation, and down-regulation of the epidermal growth factor receptor. J Biol Chem 266:11083-11094.
59. Yang LW, Bahar I. 2005. Coupling between catalytic site and collective dynamics: A requirement for mechanochemical activity of enzymes. Structure 13:893-904.
60. Yang LW, Liu X, Jursa CJ, Holliman M, Rader AJ, Karimi HA, Bahar I. 2005. iGNM: A database of protein functional motions based on Gaussian Network Model. Bioinformatics 21:2978-2987.
61. Zagzag D, Shiff B, Jallo GI, Greco MA, Blanco C, Cohen H, Hukin J, Allen JC, Friedlander DR. 2002. Tenascin-C promotes microvascular cell migration and phosphorylation of focal adhesion kinase. Cancer Res 62:2660-2668.
62. Zanuttin F, Guarnaccia C, Pintar A, Pongor S. 2004. Folding of epidermal growth factor-like repeats from human tenascin studied through a sequence frame-shift approach. Eur J Biochem 271:4229-4240.
63. Zhou M, Felder S, Rubinstein M, Hurwitz DR, Ullrich A, Lax I, Schlessinger J. 1993. Real-time measurements of kinetics of EGF binding to soluble EGF receptor monomers and dimers support the dimerization model for receptor activation. Biochemistry 32:8193-8198.